VITRAKVI larotrectinib (as sulfate) 25 mg hard capsule bottle

Bayer Australia Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 1d64087f0d8973f3
Product Name: VITRAKVI larotrectinib (as sulfate) 25 mg hard capsule bottle
Artg Id: 320237
Artg Name: VITRAKVI larotrectinib (as sulfate) 25 mg hard capsule bottle
Sponsor: Bayer Australia Ltd
Company Detail Path: /organization/bayer-australia-ltd
Artg Date: 2020-09-07
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: REP
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/74e3eb8086e1935a5eeaa55dc9f05654.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/91c2ee80844939c64859343d93ff25a3.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

1d64087f0d8973f3

Type

Standard